Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-25 @ 2:28 AM
NCT ID:
NCT04871334
Eligibility Criteria:
Inclusion Criteria:
* Pathologically or cytologically confirmed advanced melanoma or urothelial carcinoma that failed, couldn't tolerate or refused standard treatments
* ECOG score 0 or 1;
* Part B: At least 1 measurable lesion according to RECIST 1.1
Exclusion Criteria:
* Known hypersensitivity to any ingredient of TWP-101;
* Receiving any anti-cancer drugs;
* History of serious systemic diseases;
* History of serious autoimmune diseases;
* Pregnancy or lactating women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04871334
Study Brief:
Protocol Section:
NCT04871334